Methoxphenidine (MXP) is primarily studied in the field of neuropharmacology, where its dissociative properties and receptor interactions offer valuable insight into NMDA receptor function and the broader spectrum of arylcyclohexylamine activity. It is not intended for human consumption and is used strictly in controlled experimental setups by qualified laboratories.

• NMDA Receptor Antagonism Studies: MXP acts as a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor, making it useful for understanding glutamate signaling pathways and their implications in neuroplasticity, memory, and dissociation.

• Comparative Structural Research: Its structural similarities and differences with compounds like diphenidine and methoxetamine make it a subject of interest in structure-activity relationship (SAR) research for dissociatives.

• Modeling Dissociative States: MXP is used in behavioral pharmacology to simulate dissociative or psychotomimetic states in animal models, aiding studies on consciousness, perception, and cognitive disruption.

• Neurotoxicity Profiling: Researchers explore MXP’s toxicity profile in vitro and in vivo to evaluate its impact on neuronal tissue and potential risks associated with dissociative compounds.

• Binding Affinity Assays: MXP is tested in receptor binding assays to determine its affinity toward not only NMDA receptors but also potential off-target interactions with dopamine and sigma receptors.

Proper storage of Methoxphenidine (MXP) is essential to preserving its chemical integrity and ensuring reliable experimental results. Being a fine powder with potential hygroscopic properties, MXP requires specific environmental conditions to remain stable over time.

• Keep in Airtight Containers: Exposure to air and moisture can degrade the compound. Use airtight, moisture-resistant containers to maintain the compound’s physical and chemical stability.

• Store in a Cool Environment: Room temperature (not exceeding 25°C or 77°F) is generally sufficient. Avoid exposure to direct heat sources, which may accelerate degradation.

• Low Humidity is Crucial: Humid environments can cause MXP to clump or dissolve slightly, compromising its purity and consistency. Store in a desiccated or dry location.

• Protection from Light: Light, especially UV rays, can cause photochemical reactions. MXP should be stored in amber or opaque containers to block light exposure.

• Avoid Frequent Handling: To prevent contamination, researchers should minimize direct handling and always use sterile scoops or tools.

• Label and Date Samples: Proper labeling (including batch number and date of receipt) ensures traceability and helps monitor compound viability over time.

The legality of Methoxphenidine (MXP) varies significantly across regions due to its classification as a research chemical and structural similarity to controlled substances. Researchers must always verify their local regulations before purchasing or handling MXP.

• Unscheduled in Many Regions: In countries where MXP is not specifically listed under controlled substances, it may be legally acquired for research use by qualified professionals.

• Research Use Disclaimer: RC Plug supplies MXP strictly for scientific research purposes and clearly labels it as not for human consumption or clinical use.

• Customs Variability: Even in regions where MXP is unscheduled, customs authorities may treat it cautiously due to its chemical class. Discreet labeling and documentation are critical for smooth delivery.

• Analogue Laws May Apply: Some jurisdictions enforce analogue laws, which regulate substances structurally similar to controlled drugs. MXP may fall under these laws depending on its intended use or chemical structure.

• Institutional Purchases Are Safer: Accredited research facilities are more likely to clear legal scrutiny when importing or possessing MXP for laboratory purposes.

• Due Diligence Required: Researchers should consult local authorities, regulatory databases, or legal counsel if unsure about the current legal status of MXP in their country.

Although both Methoxphenidine (MXP) and Methoxetamine (MXE) are dissociative arylcyclohexylamines, they differ structurally and pharmacologically. Understanding these distinctions helps researchers select the most suitable compound for specific types of receptor, behavioral, or toxicity studies.

• Structural Differences: MXE features a ketone group in its structure, classifying it as a ketone-substituted arylcyclohexylamine, whereas MXP lacks this group and is derived from diphenidine.

• Potency and Duration: MXE is typically more potent than MXP on a per-milligram basis. MXP generally has a longer duration of action, often extending 4–6 hours in observed models, compared to MXE’s 3–5 hours.

• Onset of Action: MXE exhibits a faster onset, often within 15–45 minutes in research subjects, while MXP has a slower onset, usually around 30–60 minutes.

• Receptor Affinity Profile: Both compounds target the NMDA receptor, but MXE has additional affinity for dopamine and serotonin transporters, which may contribute to its more complex pharmacodynamic profile.

• Legal Classification: MXE is a controlled substance in many countries due to its popularity and documented recreational misuse, whereas MXP remains unscheduled in several jurisdictions, making it more accessible for legal research.

• Solubility Characteristics: MXE is slightly more soluble in aqueous solutions than MXP, which may influence its usage in liquid-phase assays.

Working with Methoxphenidine (MXP) requires adherence to standard lab safety procedures, given its potent psychoactive properties and lack of comprehensive toxicity data. Safe handling protects researchers and ensures the integrity of experimental data.

• Use Personal Protective Equipment (PPE): Gloves, lab coats, and eye protection are essential when handling MXP to prevent accidental skin contact, inhalation, or ocular exposure.

• Work in a Fume Hood: Handling MXP in a controlled ventilation area minimizes the risk of inhaling airborne particles or vapors during weighing or transfer.

• Avoid Direct Skin Contact: MXP can be absorbed through the skin in small amounts. Use clean instruments and avoid touching surfaces that have been in contact with the substance.

• Label Clearly and Accurately: All containers and sample vials must be clearly labeled with compound name, batch number, and concentration to prevent mix-ups or accidental misuse.

• Isolate from Other Chemicals: To avoid cross-contamination, keep MXP samples stored separately and use dedicated tools for handling it.

• Dispose Responsibly: Follow all institutional or municipal chemical disposal protocols to safely discard unused or expired MXP samples and containers.

• Training for Lab Staff: Ensure all personnel handling MXP are adequately trained in chemical hygiene practices and understand the potential risks involved.

Mixing Methoxphenidine (MXP) with other chemicals is generally discouraged unless the interaction is the direct subject of a specific and well-controlled experiment. Due to the lack of comprehensive interaction data, combining MXP with other substances can introduce significant variables or safety concerns in a laboratory setting.

• Unpredictable Pharmacodynamics: MXP’s activity at NMDA and other receptor sites may change dramatically when combined with substances that affect dopamine, serotonin, or glutamate systems, leading to unpredictable outcomes in lab animals or models.

• Interference with Data Collection: Combining MXP with other chemicals can obscure the interpretation of experimental results, particularly in behavioral or receptor-binding studies where clean baselines are crucial.

• Unknown Toxicity Profiles: There is limited peer-reviewed data on the toxicity of MXP combinations. Mixed administration may exacerbate potential neurotoxicity or produce emergent harmful effects in vitro or in vivo.

• Risk of Synergistic Effects: As with many psychoactive dissociatives, combining MXP with other central nervous system agents may lead to synergistic effects, complicating safety assessments or triggering severe dissociation in test models.

• Recommended Isolation: For accuracy and safety, MXP is best studied alone unless the research explicitly involves chemical interaction profiling or drug synergy analysis.

• Laboratory Protocol Compliance: Many research institutions and ethical committees require compounds to be studied in isolation unless prior approval is granted for combination studies.

Methoxphenidine (MXP), when stored correctly, is chemically stable for extended periods, making it a practical option for ongoing laboratory research. However, its shelf life can be compromised by poor storage conditions, especially exposure to heat, moisture, or light.

• Shelf Life of 24 Months: Under optimal conditions, MXP maintains structural and functional stability for approximately two years from the date of synthesis or packaging.

• Susceptible to Moisture: MXP is hygroscopic, meaning it can absorb moisture from the air. Humidity can reduce powder integrity, cause clumping, or even promote hydrolysis.

• Stable in Dry, Dark Environments: The compound remains chemically unchanged when stored in airtight containers at room temperature and away from light.

• No Refrigeration Required: While refrigeration can extend the shelf life of some chemicals, MXP remains stable at standard lab temperatures when sealed properly.

• Visual Checks Recommended: Changes in texture (e.g., clumping, color shifts) may indicate degradation. Regular inspections of stored samples help ensure reliability in experiments.

• Avoid Frequent Opening: Each time a container is opened, the sample may be exposed to environmental factors. Frequent exposure should be minimized to extend stability.

Yes, we uphold strict quality control standards for every product we supply, including Methoxphenidine (MXP). Purity testing ensures that researchers receive a compound that performs reliably and consistently across experiments.

• Third-Party Lab Verification: Each batch is tested in certified independent laboratories to confirm composition, identity, and purity levels using techniques such as gas chromatography–mass spectrometry (GC-MS) or nuclear magnetic resonance (NMR).

• Minimum 98% Purity Guarantee: We do not release MXP batches for sale unless they meet or exceed our minimum quality threshold of 98% purity, ensuring minimal impurity interference.

• Certificate of Analysis Available: Upon request, researchers can obtain a Certificate of Analysis (COA) detailing analytical results, synthesis date, batch number, and testing method.

• Consistent Batch Testing: All batches are independently verified to ensure consistency in purity, morphology, and chemical behavior across product lots.

• Internal Quality Assurance: Our in-house team performs an additional screening on incoming product before shipping to detect any anomalies in appearance, odor, or form.

• Transparent Sourcing: We work exclusively with suppliers who meet GMP-like conditions for synthesis and handling, reducing contamination risks and ensuring traceability.

At RC Plug, Methoxphenidine (MXP) is offered in its most stable and research-friendly form: a fine crystalline powder. This form ensures precise dosing, long shelf life, and flexible application across a wide range of experimental procedures.

• Crystalline Powder: The standard form we provide is a high-purity, free-flowing powder. This format is ideal for accurate weighing, dissolution, or suspension in lab media.

• No Capsules or Liquid Formulations: To maintain purity and versatility, we do not offer MXP in pre-capsulated or liquid form. This ensures researchers retain full control over formulation and dosing protocols.

• Bulk Packaging Available: For institutional or high-volume use, MXP is available in securely sealed bulk pouches with batch numbers and purity verification included.

• Sterile Packaging: Each order is packed in sterile, tamper-evident containers to prevent contamination during shipping and storage.

• Flexible Sizing: From micro-quantities for pilot tests to larger packages for repeated assays, we offer multiple sizing options to suit individual research requirements.

Yes, Methoxphenidine (MXP) is considered psychoactive based on its pharmacological activity at NMDA receptors and its classification within the arylcyclohexylamine dissociative family. However, its use is strictly limited to controlled laboratory studies and not approved for human consumption or therapeutic application.

• Dissociative Effects: Like ketamine and PCP, MXP is a potent NMDA receptor antagonist, leading to alterations in perception, cognition, and awareness in test models.

• Animal Behavior Studies: In preclinical environments, MXP has been used to simulate states of derealization, amnesia, and locomotor disruption, mirroring dissociative effects observed in other compounds.

• Central Nervous System Activity: Its ability to suppress glutamate-driven excitatory transmission places MXP in a category of agents that can profoundly influence neurological activity.

• Receptor Specificity: While its main action is on NMDA receptors, MXP may have mild interactions with other targets (e.g., dopamine receptors), contributing to its complex psychotropic profile.

• Non-Therapeutic Use Warning: MXP is not recognized as safe for medical or recreational use. It lacks clinical trials, regulatory approval, and long-term human safety data.

• Sold for Research Only: At RC Plug, we make clear that MXP is offered solely for chemical research, modeling, and receptor studies — not for ingestion or self-experimentation.

Methoxphenidine (MXP) exerts its primary pharmacological action by antagonizing the NMDA (N-methyl-D-aspartate) receptor, a key receptor subtype involved in glutamatergic neurotransmission. This interaction forms the foundation of its dissociative properties and makes it an important compound in neuropharmacological studies of cognition, perception, and neural excitability.

• Non-Competitive Antagonist: MXP binds to the NMDA receptor at a site distinct from the glutamate binding site, preventing the ion channel from opening, which inhibits calcium influx and neuronal firing.

• Inhibition of Excitatory Signaling: By blocking NMDA receptor activation, MXP disrupts normal excitatory neurotransmission, making it useful for modeling the neurological mechanisms of anesthesia, psychosis, or memory disruption.

• Studied in Neuroprotection Research: NMDA receptor overactivation is linked to excitotoxicity and neuronal damage in conditions like stroke and epilepsy. MXP’s antagonistic effects offer a basis for investigating neuroprotective strategies.

• Cognition and Behavior Impact: Research models using MXP have demonstrated impairments in learning, spatial memory, and sensorimotor gating — mimicking schizophrenia-like symptoms.

• Dose-Dependent Effects: The extent of NMDA inhibition varies by dose, enabling researchers to study graded receptor antagonism in a controlled setting.

While Methoxphenidine (MXP) and Phencyclidine (PCP) are both classified as dissociative arylcyclohexylamines and share NMDA receptor antagonism as a common mechanism, their pharmacological profiles, potency, and legal treatment differ significantly. Their comparison is often studied in the context of receptor specificity and behavioral pharmacology.

• Structural Relation: Both are part of the same chemical family, but MXP is a diphenidine analog whereas PCP has a more rigid cyclohexylamine structure with a higher affinity for sigma receptors.

• Reduced Potency: MXP is generally considered less potent and less psychoactive than PCP, which has a notorious reputation for inducing severe dissociation and aggression in high doses.

• Distinct Receptor Affinity Profiles: PCP has strong binding affinity not only to NMDA receptors but also to dopamine and sigma-1 receptors. MXP’s activity is more selective, which may contribute to its milder psychoactive effects in lab models.

• Lower Abuse Liability: Although both are dissociatives, MXP has shown less potential for abuse or compulsive use in observational research compared to PCP.

• Legal Classification Difference: PCP is a Schedule II controlled substance in many jurisdictions due to its abuse history. MXP, on the other hand, is often not scheduled and remains available for research in more regions.

• Research Preference: MXP is preferred in modern research environments due to its lower public stigma and reduced risk of causing violent or erratic behavior in test models.

Yes, at RC Plug we stand behind the quality and integrity of our products, including Methoxphenidine (MXP). If your order arrives damaged, contaminated, or not as described, we provide full support through our return or replacement policy.

• 30-Day Return Policy: Customers have up to 30 days from the date of delivery to report and return damaged or compromised products for a full refund or replacement.

• No-Hassle Replacement: Once photographic or documented evidence of the damage is reviewed and approved, we immediately initiate a re-shipment of the product.

• Refund Option Available: If a replacement is not feasible or desired, we offer a full refund through the same payment method used.

• Secure Re-Packaging: We take full responsibility if improper packaging contributed to the product’s damage and will adjust future shipments accordingly.

• Responsive Customer Support: Our dedicated support team ensures that all return requests are resolved swiftly and professionally, with attention to customer satisfaction.

We understand that different research environments require different quantities of Methoxphenidine (MXP). At RC Plug, we offer a flexible range of sizing options to meet the unique needs of both independent researchers and institutional laboratories.

• Micro Quantities (250 mg – 1 g): Ideal for initial sampling, solubility testing, or pilot experiments that require small, precise doses.

• Standard Laboratory Batches (2 g – 10 g): Commonly used for recurring research applications, stability tests, and long-term studies.

• Bulk Orders (25 g – 100 g+): Available for university departments or high-throughput screening labs. These come with additional documentation, including COA and material safety data sheets (MSDS) upon request.

• Custom Quantities: Researchers with specific needs can contact us for tailored orders outside standard packaging sizes.

• Secure Packaging Across All Sizes: Regardless of quantity, every order is vacuum-sealed, tamper-evident, and properly labeled with batch numbers.

• Volume Discounts: We provide pricing incentives for bulk orders and repeat customers with a consistent purchasing history.

Standard drug testing panels (e.g., 5-panel or 10-panel urine tests) typically do not detect Methoxphenidine (MXP) due to its novel structure and limited recreational footprint. However, in advanced forensic or custom toxicological screens, MXP may be identified.

• Not Part of Routine Panels: Workplace or law enforcement drug tests usually target controlled substances such as opiates, amphetamines, benzodiazepines, and THC — MXP does not fall within these categories.

• Detectable in Specialized Labs: High-resolution testing using techniques like LC-MS/MS (liquid chromatography–mass spectrometry) can detect MXP and its metabolites, if specifically programmed to do so.

• No Cross-Reactivity with PCP Tests: Despite structural similarities, MXP does not typically trigger false positives for PCP or ketamine in standard assays.

• Used in Analytical Research: Some labs include MXP in targeted panels for research on new psychoactive substances (NPS), especially in countries tracking designer dissociatives.

• Not Scheduled = Not Tested: In most jurisdictions, unscheduled compounds like MXP are not prioritized in routine testing environments.

Yes, RC Plug provides discreet and compliant shipping of Methoxphenidine (MXP) to both the United States and countries within the European Union, provided local laws permit the importation of unscheduled research chemicals. Our logistics process is designed to minimize customs delays and protect the integrity of your order.

• USA Shipments: We regularly ship to laboratories and research professionals in the United States. While MXP is not federally scheduled, researchers are advised to confirm local or state-level regulations prior to purchase.

• European Union Shipments: MXP is legally accessible in several EU countries. We encourage EU researchers to verify their country’s stance on arylcyclohexylamine compounds before ordering.

• Customs Clearance Support: All packages are discreetly labeled with generic product codes and declarations to improve customs clearance success rates.

• Plain and Secure Packaging: Orders are shipped in tamper-proof, unlabeled packaging with no references to chemical names or supplier identity.

• Replacement Guarantee: If your shipment is seized or fails to clear customs, we offer reshipments or a full refund depending on the circumstances.

• Fast Delivery Options: We provide express and overnight options for North American and European customers seeking fast turnaround.